This brief reports on the findings of the task force assembled by the New York Academy of Sciences (NYAS) which developed a special report to help countries determine if they should transition from Iron Folic Acid (IFA) to Multiple Micronutrient Supplements (MMS) in antenatal care given the superior health benefits of MMS over IFA for pregnant women and its cost-effectiveness.
